goralatide has been researched along with nephrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carretero, OA; Pokharel, S; Rhaleb, NE; Sharma, U | 1 |
| Bombardi, C; Castoldi, G; Corradi, B; di Gioia, CR; Leopizzi, M; Maestroni, S; Preziuso, C; Stella, A; Zerbini, G | 1 |
2 other study(ies) available for goralatide and nephrin
| Article | Year |
|---|---|
Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Collagen; Desoxycorticosterone; Hypertension, Renal; Kidney; Macrophages; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Oligopeptides; Sodium Chloride, Dietary | 2011 |
Renal antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Nephropathies; Drug Evaluation, Preclinical; Glomerular Filtration Rate; Growth Inhibitors; Kidney Glomerulus; Male; Membrane Proteins; Nephrosclerosis; Oligopeptides; Ramipril; Rats; Rats, Sprague-Dawley | 2013 |